Overview
Cleft lip/palate-intestinal malrotation-cardiopathy syndrome (also known as Toriello-Carey syndrome) is an extremely rare congenital malformation syndrome characterized by the combination of orofacial clefting, intestinal malrotation, and cardiac defects. The condition is typically apparent at birth and affects multiple organ systems. Key clinical features include cleft lip and/or cleft palate, malrotation of the intestines (abnormal positioning of the bowel that can lead to obstruction), and congenital heart defects of variable type and severity. Additional features that have been reported in affected individuals include Robin sequence (micrognathia, glossoptosis, and cleft palate), laryngeal and subglottic abnormalities, central nervous system anomalies such as agenesis of the corpus callosum, and intellectual disability. Some patients may also present with hypotonia and short stature. The syndrome was first described by Toriello and Carey, and only a small number of cases have been reported in the medical literature, making it difficult to fully delineate the clinical spectrum. The prognosis depends largely on the severity of the cardiac and gastrointestinal malformations. Treatment is supportive and symptom-based, typically requiring a multidisciplinary approach. Surgical intervention is often necessary for the cleft lip/palate repair, correction of intestinal malrotation (Ladd procedure), and repair of congenital heart defects. Ongoing monitoring by specialists in cardiology, gastroenterology, genetics, and developmental pediatrics is recommended. There is no specific cure or targeted therapy for this syndrome, and management focuses on addressing individual malformations and optimizing developmental outcomes.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.
Community
No community posts yet. Be the first to share your experience with Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.
Start the conversation →Latest news about Cleft lip/palate-intestinal malrotation-cardiopathy syndrome
No recent news articles for Cleft lip/palate-intestinal malrotation-cardiopathy syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cleft lip/palate-intestinal malrotation-cardiopathy syndrome
What is Cleft lip/palate-intestinal malrotation-cardiopathy syndrome?
Cleft lip/palate-intestinal malrotation-cardiopathy syndrome (also known as Toriello-Carey syndrome) is an extremely rare congenital malformation syndrome characterized by the combination of orofacial clefting, intestinal malrotation, and cardiac defects. The condition is typically apparent at birth and affects multiple organ systems. Key clinical features include cleft lip and/or cleft palate, malrotation of the intestines (abnormal positioning of the bowel that can lead to obstruction), and congenital heart defects of variable type and severity. Additional features that have been reported in
How is Cleft lip/palate-intestinal malrotation-cardiopathy syndrome inherited?
Cleft lip/palate-intestinal malrotation-cardiopathy syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Cleft lip/palate-intestinal malrotation-cardiopathy syndrome typically begin?
Typical onset of Cleft lip/palate-intestinal malrotation-cardiopathy syndrome is neonatal. Age of onset can vary across affected individuals.